NeoPhore Ltd Employee Directory
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Broadening cancer patient access to powerful disease-transforming immunotherapy. Our therapeutic approach transiently blocks DNA Mismatch Repair (MMR) to mimic the known robust and durable clinical responses to immunotherapy of patients with genetically MMR-deficient tumours. Our medicine will bring the proven therapeutic benefits of cancer immunotherapy to substantially more cancer patients.